HIVACAT: HIV Vaccine Development

The HIVACAT AIDS vaccine research and development project is a joint Public and Private Partnership (PPP) with a unique architecture at the forefront of international HIV and AIDS research. The program aims to develop a prophylactic vaccine and therapeutic vaccine against HIV/AIDS.

HIVACAT: HIV Vaccine Development

The development of an effective vaccine is the only affordable and sustainable way to halt the HIV pandemic. In response to this challenge, the HIVACAT program was launched to design, develop and test potential HIV vaccine candidates in clinical trials for further development and regulatory approval. HIVACAT is a joint effort of two leading European HIV research institutions in Barcelona – The Hospital Clinic and Irsicaixa, and the pharmaceutical company, Esteve. This consortium also has the support of the Obra Social “La Caixa” Foundation (“Fundació la Caixa”) and two organizations of the government of the Generalitat de Catalunya (the Department of Health and the Department of Innovation, Universities and Companies). HIVACAT brings together the expertise and projects of more than 60 investigators from The Hospital Clinic and Irsicaixa, in addition to multiple international collaborations with leading HIV research organizations and institutions in Europe, Asia, Africa, Oceania and the Americas. Esteve's involvement consists in providing expertise in intellectual property, regulatory affairs, GMP production, GLP regulatory studies, and other aspects of preclinical and clinical development, in addition to providing funding.


  • Esteve

    Goods Supplier
    Spain | Staff size: 1001-5000

    ESTEVE is an international pharmaceutical chemical group that focuses its efforts on innovation and excellence in the field of health, striving daily to achieve customer satisfaction and to...

  • IrsiCaixa

    Spain | Staff size: 101-250

    The IrsiCaixa Institute for AIDS Research is an internationally-recognized oraganization with the aim of contributing to improving understanding of the disease, its prevention and...

  • Obra Social "la Caixa"

    Staff size: Unknown

More Resources

Key Information

  • Start Date 2008